2.5. Crhr2 Deficiency Promotes Tumor Development and Growth in the Azoxymethane (AOM) and Dextran Sulfate Sodium (DSS)-Treated Model of Colon Cancer, While Crhr1 Deletion Does Not Alter the Tumorigenesis. Here, CRHR1 is linked to neoplasm.